HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities.

Abstract
Treatment of severe arteriosclerosis obliterans of lower extremities (ASOLE) remains a clinical challenge. To develop a more effective approach, we evaluated the clinical efficacy of autologous transplantation of mobilized peripheral blood stem cells (PBSCs) in 5 patients with ASOLE. The patients received recombinant human granulocyte colony-stimulating factor (rhG-CSF, 600 micro g/day) for 5 consecutive days. On day 5, PBSCs were collected, sorted from blood circulation of patients, and then intramuscularly injected into their ischemic lower limbs. A significant improvement of clinical manifestations including severe pain, skin temperature and ulcer, was observed, without obvious adverse effect. The patient's limb was successfully saved. Satisfactory remission was obtained 3 months after transplantation as shown by significant improvement in ankle-brachial pressure index (ABI), blood flow in personal vascular laboratory (PVL), laser Doppler blood perfusion, and the angio-graphic scores. Our data suggest for the first time that autologous transplantation of mobilized PBSCs provides a practical, safe, and effective method of treatment for lower limb ischemia.
AuthorsPing Ping Huang, Shan Zhu Li, Ming Zhe Han, Zhi Jian Xiao, Ren Chi Yang, Lu Gui Qiu, Zhong Chao Han
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 91 Issue 3 Pg. 606-9 (Mar 2004) ISSN: 0340-6245 [Print] Germany
PMID14983238 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Granulocyte-Macrophage Colony-Stimulating Factor
Topics
  • Aged
  • Angiography
  • Arteriosclerosis Obliterans (therapy)
  • Body Temperature
  • Granulocyte Colony-Stimulating Factor (metabolism)
  • Granulocyte-Macrophage Colony-Stimulating Factor (therapeutic use)
  • Humans
  • Laser-Doppler Flowmetry
  • Lower Extremity (pathology)
  • Middle Aged
  • Pain
  • Perfusion
  • Recombinant Proteins (therapeutic use)
  • Stem Cell Transplantation (methods)
  • Stem Cells (cytology)
  • Time Factors
  • Transplantation, Autologous (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: